{
  "id": 15842820,
  "title": "Cosmax joins Harvard-affiliated hospital network to pursue anti-aging, metabolic research",
  "url": "https://urgent.news/2026/10/21/cosmax-joins-harvard-affiliated-hospital-network-to-pursue-anti-aging",
  "topic": "world",
  "section": "World",
  "published": "2026-10-21T04:12:03.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times-koreatimes",
    "url": "https://www.koreatimes.co.kr/business/companies/20261021/cosmax-joins-harvard-affiliated-hospital-network-to-pursue-anti-aging-metabolic-research"
  },
  "original_language": "en",
  "account": "Cosmax Group, the Korean cosmetics manufacturer, is expanding its focus from skincare to medical and biotechnology research by joining a partnership with a Harvard-affiliated hospital network. The agreement, signed on October 13 in Boston, aims to explore treatments and health products related to aging, weight management, and metabolic health.\n\nThis partnership, known as the VIVA project, is set to begin its second phase from 2026 to 2029. During this period, Cosmax and Mass General Brigham (MGB) will broaden their research beyond cosmetic ingredients to include functional ingredients for health supplements and potential drug candidates.\n\nThe collaboration builds upon research conducted from 2024 to 2026, which identified a substance derived from certain microorganisms that alleviated symptoms of atopic dermatitis and improved skin barrier function. This discovery, published in the international journal Allergy, has led Cosmax to file a Korean patent application related to the microbial technology.",
  "summary": "Cosmax Group is moving beyond cosmetics into medical and biotechnology research through an expanded partnership with a Harvard-affiliated hospital network, targeting potential treatments and health products for aging, weight management and metabolic health. The Korean cosmetics manufacturer said Tuesday it signed an agreement Oct. 13 in Boston with Mass General Brigham (MGB) to launch the second…",
  "key_points": [
    "Cosmax Group joins Harvard-affiliated Mass General Brigham for anti-aging research.",
    "VIVA project to expand research on health products and drug candidates from 2026-2029.",
    "Microbial substance from 2024-2026 study alleviates atopic dermatitis symptoms."
  ],
  "editors_take": "Cosmax is pivoting from traditional skincare into the biotechnology sector by leveraging academic partnerships to transform cosmetic ingredients into functional health supplements and potential pharmaceutical drug candidates.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Korea Times",
        "title": "Cosmax joins Harvard-affiliated hospital network to pursue anti-aging, metabolic research",
        "url": "https://urgent.news/2026/10/21/cosmax-joins-harvard-affiliated-hospital-network-to-pursue-anti-aging-15846800",
        "published": "2026-10-21T05:02:03.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}